Traws Pharma, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €194.95K +0.0% -€143.64M +778.8% -73,682.7% -650 pp -€25.70M +66.3% -13,182.3% -53 pp
    €194.95K +0.0% -€16.34M -0.1% -8,384.1% +0.071 pp -€15.46M +10.0% -7,928.3% -7.2 pp
    €194.95K +0.0% -€16.36M +17.3% -8,391.2% -12 pp -€14.06M -16.4% -7,209.7% +14 pp
    €194.95K -2.2% -€13.94M -35.8% -7,151.8% +37 pp -€16.81M -15.5% -8,622.6% +14 pp
    €199.26K -89.4% -€21.70M +17.0% -10,890.5% -99 pp -€19.89M +11.0% -9,982.7% -90 pp
    €1.88M +77.8% -€18.55M +4.5% -985.0% +6.9 pp -€17.92M -8.5% -951.7% +9.0 pp
    €1.06M +56.0% -€17.75M -14.6% -1,675.3% +14 pp -€19.58M -4.7% -1,848.2% +12 pp
    €678.86K -85.8% -€20.78M +22.5% -3,061.2% -27 pp -€20.55M +50.6% -3,026.7% -27 pp
    €4.78M -51.6% -€16.96M -18.0% -354.6% -1.5 pp -€13.64M -49.4% -285.1% -0.12 pp
    €9.88M +1,332.0% -€20.68M -62.3% -209.3% +78 pp -€26.95M -45.6% -272.7% +69 pp
    €690.07K -83.2% -€54.93M +1.8% -7,960.3% -66 pp -€49.53M -5.5% -7,177.5% -59 pp
    €4.10M -89.7% -€53.95M +109.1% -1,315.9% -13 pp -€52.42M -3,278.6% -1,278.7% -13 pp
    €39.84M +3,006.3% -€25.80M +13.8% -64.8% +17 pp €1.65M -113.7% 4.1% +9.4 pp
    €1.28M -€22.68M -1,768.3% -€12.00M -935.8%

    Notifications